Edoxaban NOBEL 15 mg
Edoxaban NOBEL 15 mg is a medicine authorised by Swissmedic under authorisation number 70146. The authorisation holder is NOBEL Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 July 2026 and the authorisation is limited until 13 July 2031. ATC code B01AF03 places the medicine in the group Antithrombotic agents.
| Authorisation number | 70146 |
|---|---|
| Name | Edoxaban NOBEL 15 mg |
| Full name | Edoxaban NOBEL 15 mg, Filmtabletten |
| Authorisation holder | NOBEL Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B01AF03 |
| First authorisation | 14 July 2026 |
| Authorisation validity | 13 July 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Edoxaban NOBEL 15 mg, Filmtabletten | B | 14 July 2026 |
| 2 | Edoxaban NOBEL 30 mg, Filmtabletten | B | 14 July 2026 |
| 3 | Edoxaban NOBEL 60 mg, Filmtabletten | B | 14 July 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Tablette(n) | B01AF03 | 06.03.0. | B |
| 2 | 28 | Tablette(n) | B01AF03 | 06.03.0. | B |
| 3 | 98 | Tablette(n) | B01AF03 | 06.03.0. | B |
| 4 | 28 | Tablette(n) | B01AF03 | 06.03.0. | B |
| 5 | 98 | Tablette(n) | B01AF03 | 06.03.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Edoxaban NOBEL 15 mg authorised in Switzerland?
Yes. Edoxaban NOBEL 15 mg is authorised by Swissmedic under authorisation number 70146, data as of 01 September 2026. The authorisation is limited until 13 July 2031.
Which dispensing category does Edoxaban NOBEL 15 mg have?
Edoxaban NOBEL 15 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Edoxaban NOBEL 15 mg?
The authorisation holder is NOBEL Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.